Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine hydrochloride 20mg/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluoxetine and olanzapine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 20 mg oral tablet |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 25 mg and olanzapine 6 mg oral capsule |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Fluoxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |